Area of research
Infectious Diseases · Pulmonary and Respiratory Medicine
Research interest
Research interests include COVID-19 Clinical Research Studies, Pleural and Pulmonary Diseases, Long-Term Effects of COVID-19, and SARS-CoV-2 and COVID-19 Research.
Outcomes of radiologically diagnosed solitary fibrous tumours of the pleura.
Burden of respiratory syncytial virus infection in older adults hospitalised in England during 2023/24.
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospitalisation among adults aged 75-79 years in England
Estimating the disease burden of respiratory syncytial virus (RSV) in older adults in England during the 2023/24 season: a new national hospital-based surveillance system
Understanding post-hospitalised patients' experiences of long COVID - the PELCO study.
The role of interleukin-6 signalling in pleural infection: observational and genetic analyses.
First-line medical thoracoscopy for pleural infection: the SPIRIT randomised controlled feasibility trial.
The DEXACELL Trial – a protocol for a pragmatic, multicentre, double-blind, placebo-controlled, randomised, parallel group, phase 3 superiority trial to assess the effectiveness and cost-effectiveness of DEXAmethasone as an adjunctive therapy for the management of CELLulitis in adults presenting to urgent secondary care in the UK
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
Accelerated immune ageing is associated with COVID-19 disease severity
PET-CT-guided <i>versus</i> CT-guided biopsy in suspected malignant pleural thickening: a randomised trial.
Antibiotic pharmacokinetics in infected pleural effusions.
Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study.
Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months.
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19.
Bad research is not all bad.
Parapneumonic effusions related to <i>Streptococcus pneumoniae</i>: serotype and disease severity trends from 2006 to 2018 in Bristol, UK.
Antibiotic pharmacokinetics in infected pleural effusions
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection
Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems.
Randomised trial of indwelling pleural catheters for refractory transudative pleural effusions.
Are aerosols generated during lung function testing in patients and healthy volunteers? Results from the AERATOR study.
A feasibility randomised trial comparing therapeutic thoracentesis to chest tube insertion for the management of pleural infection: results from the ACTion trial.
Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma.
Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2.
Evaluation of perturbed iron-homeostasis in a prospective cohort of patients with COVID-19.
Corticosteroids for Pleural Infection: Should We STOPPE Studying?